Australia's most trusted
source of pharma news
Wednesday, 22 January 2025
Posted 18 November 2024 PM
Medicines Australia has reiterated calls for an effective horizon scanning process to ensure Australia's health technology assessment system can cope with the surge of new treatments in development.
The call comes mere weeks after PBAC was forced to defer consideration of the majority of submission to the March PBAC meeting, with the fallout from the decision still ongoing.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.